Pressor and renal vasoconstrictor responses to acute systemic nitric oxide synthesis inhibition are independent of the sympathetic nervous system and angiotensin II

J Pharmacol Exp Ther. 1999 Feb;288(2):693-8.

Abstract

Acute systemic, nonselective nitric oxide synthesis inhibition (NOSI) causes a marked pressor and renal vasoconstrictor response in the normal conscious chronically catheterized rat. The present studies directly address the question of how these vasoconstrictor responses are related to the combined vasoconstrictor activities of the sympathetic nervous system and angiotensin II. When the alpha adrenoceptors are blocked (with prazosin) the pressor and renal hemodynamic responses to NOSI are unaffected. Combined alpha adrenoceptor and angiotensin II receptor blockade at the same time as NOSI results in no net change in blood pressure while leaving the renal vasoconstrictor response intact. However, when the NOSI is delayed, a substantial and unblunted pressor response is seen. In contrast to the vasoconstrictor responses, the natriuretic and diuretic responses to acute NOSI are prevented by simultaneous alpha adrenoceptor blockade alone and combined with angiotensin II receptor blockade. These findings suggest that the hemodynamic actions of acute NOSI in the unstressed rat are independent of the sympathetic nervous system and angiotensin II. In contrast, the natriuretic/diuretic response to acute NOSI is apparently partly the result of some interaction with the sympathetic nervous system, not, as we had previously suggested, exclusively the result of a pressure natriuresis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenergic alpha-Antagonists / pharmacology
  • Angiotensin Receptor Antagonists
  • Animals
  • Antihypertensive Agents / pharmacology
  • Blood Pressure / drug effects
  • Blood Pressure / physiology*
  • Enzyme Inhibitors / pharmacology
  • Kidney / blood supply
  • Kidney / innervation
  • Kidney / physiology*
  • Losartan / pharmacology
  • Male
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / biosynthesis*
  • Prazosin / pharmacology
  • Pressoreceptors / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Angiotensin, Type 1
  • Renal Circulation / drug effects
  • Renal Circulation / physiology*
  • Sympathetic Nervous System / drug effects
  • Sympathetic Nervous System / physiology
  • Vasoconstriction / drug effects
  • Vasoconstriction / physiology*

Substances

  • Adrenergic alpha-Antagonists
  • Angiotensin Receptor Antagonists
  • Antihypertensive Agents
  • Enzyme Inhibitors
  • Receptor, Angiotensin, Type 1
  • Nitric Oxide
  • Losartan
  • NG-Nitroarginine Methyl Ester
  • Prazosin